Elan's $8bn makeover
ELAN is set to formally disappear from the business world after its takeover by a US pharmaceuticals firm was completed.
The deal, which values Elan at $8.6bn (€6.2bn), will create what Perrigo said would be a "global healthcare company with an industry-leading growth profile and the geographic scale and scope to continue building a truly differentiated business".
The two firms have been combined under a new name -- Perrigo Company Plc. Perrigo chairman and chief executive Joseph C Papa said that combined company establishes a diversified platform that will position Perrigo well for further expansion.